Abstract
In recent years, with the development of genetics molecular biology and plant biotechnology, the vaccination (e.g. genetic engineering subunit vaccine, living vector vaccine, nucleic acid vaccine) programs are taking on a prosperous evolvement. In particular, the technology of the use of transgenic plants to produce human or animal therapeutic vaccines receives increasing attention. Expressing vaccine candidates in vegetables and fruits open up a new avenue for producing oral/edible vaccines. Transgenic plant vaccine disquisitions exhibit a tempting latent exploiting foreground. There are a lot of advantages for transgenic plant vaccines, such as low cost, easiness of storage, and convenient immune-inoculation. Some productions converged in edible tissues, so they can be consumed directly without isolation and purification. Up to now, many transgenic plant vaccine productions have been investigated and developed. In this review, recent advances on plant-derived recombinant protein expression systems, infectious targets, and delivery systems are presented. Some issues of high concern such as biosafety and public health are also discussed. Special attention is given to the prospects and limitations on transgenic plant vaccines.
References
Nov 2, 1989·Nature·A HiattK Bowdish
Sep 1, 1995·Trends in Biotechnology·H S Mason, C J Arntzen
Feb 7, 2001·Current Opinion in Biotechnology·A M Walmsley, C J Arntzen
May 18, 2000·Microbes and Infection·C O Tacket, H S Mason
Mar 21, 2001·Vaccine·H Koprowski, V Yusibov
May 4, 2001·Trends in Plant Science·H DaniellK Wycoff
Sep 22, 2001·Biomolecular Engineering·J W LarrickK Wycoff
Nov 10, 2001·Trends in Plant Science·D ChargelegueP M Drake
Feb 8, 2002·Trends in Plant Science·Henry DaniellLori Allison
Feb 22, 2002·Current Opinion in Plant Biology·Pal Maliga
Jul 13, 2002·Trends in Molecular Medicine·Hugh S MasonCharles J Arntzen
Nov 22, 2002·Trends in Biotechnology·Ilya RaskinBertold Fridlender
Dec 12, 2002·Trends in Plant Science·Kathleen M PryerJo Ann Banks
Dec 17, 2002·Current Opinion in Biotechnology·Elizabeth E HoodMichael E Horn
Jan 18, 2003·Vaccine·Claude P MullerFabienne B Bouche
May 7, 2003·Current Opinion in Biotechnology·Amanda M Walmsley, Charles J Arntzen
Aug 2, 2003·Biochemical and Biophysical Research Communications·Rodolfo ValdésCarlos Borroto
Aug 28, 2003·Journal of Plant Physiology·Heribert Warzecha, Hugh S Mason
Aug 29, 2003·The Plant Journal : for Cell and Molecular Biology·Anthony J ConnerJan-Peter Nap
Sep 5, 2003·Virology·Yu-Zhang WuYan Tang
Sep 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·Rachel K ChikwambaKan Wang
Oct 4, 2003·Nature Reviews. Genetics·Julian K-C MaPaul Christou
Nov 20, 2003·Trends in Biotechnology·Richard M TwymanRainer Fischer
Feb 6, 2004·Trends in Biotechnology·Robert K D Peterson, Charles J Arntzen
Mar 9, 2004·Current Opinion in Plant Biology·Rainer FischerRichard M Twyman
Apr 28, 2004·Phytochemistry·John TregoningPeter J Nixon
Oct 13, 2004·Protein Expression and Purification·Tae-Jin KangMoon-Sik Yang
Nov 9, 2004·Vaccine·Jin-Yong LeeWilliam H R Langridge
Mar 1, 2005·Vaccine·D E WebsterS L Wesselingh
Mar 10, 2005·Vaccine·Jacqueline M Duggan, Timothy J G Brooks
Mar 10, 2005·Vaccine·Vidadi YusibovDean Mann
Jun 7, 2005·Advanced Drug Delivery Reviews·Vincent W BramwellH Oya Alpar
Jul 5, 2005·Virology·Jiang-Li DongTao Wang